Scroll To Top
Search by Speciality

Rheumatoid Arthritis (RA) : Therapeutic Updates and Optimizing Treatment

Hyatt Regency Sydney | Orlando, USA
From 450 to 550 USD
Event Preview
116
Days Left
For the
Event
Title: Rheumatoid Arthritis (RA) : Therapeutic Updates and Optimizing Treatment
Specialty: Internal Medicine
Dates: From Dec, 13, 2018 to Dec, 13, 2018
Location: Orlando, USA
Type: Course
Registration Cost: From 450 to 550 USD
Event Tools
  • Add to Favorites
  • Notify me by email
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Dec
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for ORLANDO, Usa.
General Info
Event Venue:

Hyatt Regency Sydney

ORLANDO, USA Visit the Venue to read more
Currency:
USD
Accreditation:

-

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: ScientiaCME designates this educational activity for a maximum of  1.0 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacists

ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1.0 hours (0.1 CEUs) of continuing education.  Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test.   Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.  ACPE # 0574-0000-16-021-H01-P.  ACPE Accreditation effective 12/13/16, expires 12/13/18. This is a Knowledge (K)-type activity.

Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Rheumatoid arthritis (RA) is a systemic autoimmune disorder in which joints, typically those in the hands and feet, become inflamed, swollen, painful, and stiff. Without appropriate treatment, the inflammation may become chronic and cause irreversible destruction of bone and cartilage in the affected joints as well as contribute to the development of clinically important co-morbid conditions with attendant morbidity and mortality. The National Arthritis Data Workgroup estimates that about 1.3 million U.S. adults (0.6% of the adult population) have RA. RA imposes a considerable disease burden. Patients with RA have substantially lower health-related quality of life (QOL) than the general population with lower overall scores for physical and mental health across all age groups. The RA disease burden also is associated with increased health care resource utilization. Notably, RA patients with low QOL are twice as likely to be hospitalized as RA patients with high QOL.


The revised 2010 ACR/European League Against Rheumatism (EULAR) Diagnostic Criteria for Rheumatoid Arthritis expanded the number of potential patients eligible for RA treatment. Moreover, guidelines governing the treatment of RA have been updated fairly recently. The literature suggests that practicing healthcare professionals are oftentimes unable to keep up with the steady publishing of literature and evolution of clinical practice, and awareness of professional guidelines is no exception.  Recently published guidelines therefore also inherently suggest a gap in medical practice and justify the need for educational programming.


Rheumatologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in rheumatology; and any other healthcare professionals with an interest in or who clinically encounter patients with RA.




Program Objectives:


By the end of the session the participant will be able to:


Describe the pathophysiology of RA such that it might inform treatment mechanisms.

Describe strengths of different professional organizations’ guidance in RA and treatment.

Identify the currently available and emerging pharmacotherapeutic treatments for management of RA and apply them to patient cases using evidence-based medicine.

Evaluate a treatment plan for a specific patient with RA to optimize safety and efficacy, suggesting modifications for improvement, including the management of comorbidities.

Describe the challenges and barriers to care associated with treating patients with RA.

Registration Needs updating Register Now
Currency:

USD

Registration Cost
Type
Early Registration

2018-08-05
Late Registration From: 2018-08-06 To: 0--
On site Registration
Registration
450
550
0

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info

Contact No.: (949) 584-9563

Email: ssachse@ScientiaCME.org

Contact
Organising Agency

Contact No.: (949) 584-9563

Email: ssachse@ScientiaCME.org

Event map
Revelant Events